Kohlberg Kravis Roberts & Co. L.P. Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001399770
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q2 2024 · 45 positions · Total reported value $3.02B · Top-10 concentration 94.2% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 33.3% · 11 new · 10 cut · 8 exited
Active Share (vs S&P 500): 99.7% · vs QQQ: 99.8% — share of the book that differs from index weights (higher = more active) · ranking
Est. Qtr Return (Q2 2026 → Q3 2026): +9.5% · vs SPY +7.4% · Prev Value $4.57B — last quarter positions weighted by this quarter price moves · ranking
Est. QTD Return (Q3 2026 → newest close): +10.9% · vs SPY +8.7% · Latest Value $4.26B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking
In its Q2 2024 13F filing, Kohlberg Kravis Roberts & Co. L.P. disclosed 45 equity positions with a combined reported value of $3.02B. The filing implies a focused portfolio: its ten largest positions account for 94.2% of reported value. HoldingsHub classifies the profile as Mid / Focused / Health Tilt / High Turnover.
The largest disclosed positions as of Q2 2024 were BTSG ($924.02M), BBIO ($786.77M), BV ($440.67M). By sector, the heaviest allocations are Health Care 59.8%, Consumer Staples 14.6%. Versus the prior quarter, allocation shifted toward Health Care (+5.9pp), Consumer Discretionary (+2.1pp) and away from Utilities (-0.8pp), Financials (-1.8pp).
Versus the prior quarter, Kohlberg Kravis Roberts & Co. L.P. opened 11 new positions, trimmed 10 and fully exited 8, a turnover rate of 33.3% of positions. The portfolio's overlap with the prior quarter was 79% of names.
The largest new positions opened in Q2 2024 were LQD ($16.09M), DXCM ($13.66M), BL ($2.98M).
Of the 8 positions fully exited versus the prior quarter, the largest were TGAN ($119.86M), EDR ($115.68M), NRG ($21.50M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q2 2024)
- LQD iShares iBoxx $ Investment Grade Corporate Bond · $16.09M
- DXCM DEXCOM INC · $13.66M
- BL BLACKLINE INC · $2.98M
- MIRM MIRUM PHARMACEUTICALS INC · $1.70M
Fully Exited (vs previous quarter)
- TGAN TRANSPHORM INC · prev qtr: $119.86M
- EDR ENDEAVOR GROUP HOLDINGS INC CLASS · prev qtr: $115.68M
- NRG NRG ENERGY INC · prev qtr: $21.50M
- NTNX NUTANIX INC · prev qtr: $10.39M · history
- KRMN KARMAN HLDGS INC · prev qtr: $3.93M
- BSY BENTLEY SYS INC · prev qtr: $3.02M
- BILI BILIBILI INC · prev qtr: $958.80K
Insider Transactions (Form 4)
Latest Kohlberg Kravis Roberts & Co. L.P. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
KKR (Kohlberg Kravis Roberts & Co.) was founded in 1976 by Jerome Kohlberg Jr. and cousins Henry Kravis and George Roberts after they left Bear Stearns, and is headquartered at 30 Hudson Yards in New York. Its 1989 leveraged buyout of RJR Nabisco turned the LBO into a household phrase.
Firm Snapshot
It is no longer just a buyout shop. KKR today runs three businesses: asset management (private equity, credit, infrastructure, real estate and capital markets), insurance (Global Atlantic, acquired in 2024) and Strategic Holdings.
Joseph Bae and Scott Nuttall became co-CEOs in 2021, with Kravis and Roberts moving to co-executive chairmen.
- Headquarters: NEW YORK, NY, United States
- SEC registration: 801-69634 (status: Approved), registered 2008-10-15
- Regulatory AUM (Form ADV): $396.78B as of 2026-09-25
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 630 private funds, of which 18 hedge funds
- Website: kkr.com
Portfolio Structure
- 79 positions · $4.26B reported value (Q3 2026)
- Top 10 holdings = 98.0% of reported value
- Largest position: BTSG (BRIGHTSPRING HEALTH SVCS INC) at 35.8%
- Average position size: $53.88M
Sector Tilt
- Health Care 66.8%
- Information Technology 12.6%
- Energy 8.8%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q3 2026: 11 new, 8 added, 10 reduced, 8 exited
- 50 positions unchanged
Reading the 13F
Most of KKR's capital sits in unlisted companies, infrastructure and private credit, so the 13F covers only a thin slice — its public-markets and permanent-capital strategies plus the Global Atlantic insurance portfolio. Treat the holdings list as a side pocket, not the firm's main book.
The firm background and strategy notes are written by HoldingsHub editors from public sources; holdings, trading and Form ADV figures come from the firm's public SEC filings. Not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
81.34M | $924.02M | 30.65% | Hold | |
| 2 |
|
31.06M | $786.77M | 26.09% | Hold | |
| 3 |
|
33.13M | $440.67M | 14.62% | Reduce | |
| 4 |
|
259.50M | $228.91M | 7.59% | Add | |
| 5 |
|
43.48M | $210.85M | 6.99% | Hold | |
| 6 |
|
10.00M | $90.50M | 3.00% | Hold | |
| 7 |
|
305.07K | $57.39M | 1.90% | Hold | |
| 8 |
|
429.38K | $46.71M | 1.55% | Hold | |
| 9 |
|
5.24M | $36.49M | 1.21% | Hold | |
| 10 |
|
980.59K | $19.35M | 0.64% | Reduce | |
| 11 |
|
150.20K | $16.09M | 0.53% | New | |
| 12 |
|
14.00M | $13.66M | 0.45% | New | |
| 13 |
|
136.79K | $11.38M | 0.38% | Reduce | |
| 14 |
|
13.56M | $11.27M | 0.37% | Add | |
| 15 |
|
10.00M | $11.12M | 0.37% | Hold | |
| 16 |
|
11.51M | $8.60M | 0.28% | Add | |
| 17 |
|
6.84M | $8.31M | 0.28% | Reduce | |
| 18 |
|
6.00M | $8.24M | 0.27% | Hold | |
| 19 |
|
6.99M | $6.81M | 0.23% | Add | |
| 20 |
|
572.35K | $6.78M | 0.23% | Hold | |
| 21 |
|
7.05M | $6.49M | 0.21% | Add | |
| 22 |
|
5.50M | $6.30M | 0.21% | Hold | |
| 23 |
|
6.00M | $5.92M | 0.20% | Reduce | |
| 24 |
|
3.04M | $5.25M | 0.17% | Hold | |
| 25 |
|
386.52K | $4.91M | 0.16% | Reduce | |
| 26 |
|
4.83M | $4.40M | 0.15% | Add | |
| 27 |
|
2.50M | $3.87M | 0.13% | Reduce | |
| 28 |
|
4.16M | $3.75M | 0.12% | Add | |
| 29 |
|
3.46M | $3.27M | 0.11% | Add | |
| 30 |
|
3.28M | $3.00M | 0.10% | Add | |
| 31 |
|
3.00M | $2.98M | 0.10% | New | |
| 32 |
|
3.43M | $2.97M | 0.10% | Add | |
| 33 |
|
3.10M | $2.83M | 0.09% | Add | |
| 34 |
|
2.71M | $2.47M | 0.08% | Add | |
| 35 |
|
2.65M | $2.29M | 0.08% | Add | |
| 36 |
|
1.20M | $2.06M | 0.07% | Hold | |
| 37 |
|
2.10M | $2.02M | 0.07% | Add | |
| 38 |
|
1.26M | $1.70M | 0.06% | New | |
| 39 |
|
1.12M | $1.16M | 0.04% | Add | |
| 40 |
|
967.00K | $926.84K | 0.03% | Add | |
| 41 |
|
840.00K | $868.25K | 0.03% | Add | |
| 42 |
|
762.00K | $769.24K | 0.03% | Reduce | |
| 43 |
|
424.00K | $396.86K | 0.01% | Add | |
| 44 |
|
230.00K | $288.65K | 0.01% | Reduce | |
| 45 |
|
190.00K | $210.50K | 0.01% | Reduce | |
FAQ
What did Kohlberg Kravis Roberts & Co. L.P. buy in 2024-Q2?
In its 2024-Q2 13F filing, Kohlberg Kravis Roberts & Co. L.P. reported 45 equity positions worth $3.02B in aggregate; its largest disclosed positions were BTSG ($924.02M), BBIO ($786.77M), BV ($440.67M).
How large is Kohlberg Kravis Roberts & Co. L.P.'s portfolio?
Kohlberg Kravis Roberts & Co. L.P. reported $3.02B of long equity holdings across 45 positions as of 2024-Q2. Top-10 holdings account for 94.2% of reported value.
What is Kohlberg Kravis Roberts & Co. L.P.'s investment style?
HoldingsHub classifies the portfolio as Mid / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.